News

Press Release

Go to Topics

Back number

2019

Notice of Decisions on the Details of Stock Option Issuance (PDF:170KB)
Sysmex Launches Caresphere™ QM, an Operational Support System for Testing Quality Management
-Realizing the Operation of High-Quality Clinical Laboratories through our New Caresphere™ Solution-
Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Fourth Consecutive Year
Japan’s First Automated Hematology Analyzer Registered by the National Museum of Nature and Science as “Essential Historical Material for Science and Technology”
-Using Unique Technology to Cultivate True Automation in Blood Cell Counting-
Issuance of Stock Options (Stock Acquisition Rights) (PDF:201KB)
Sysmex Launches its Sample Preparation System PS-10 in North America, a New Product to Make Clinical Flow Cytometry Testing More Efficient
Summary of Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2020 (PDF:347KB)
Sysmex Obtains First Manufacturing and Marketing Approval in Japan for Blood-Based RAS Gene Mutation Testing for Colorectal Cancer
Sysmex Receives the 44th Inoue Harushige Prize
Our Views and Policy regarding Investment Unit Reduction (PDF:81KB)
World Anti-Doping Agency Coordinates Global Implementation of Sysmex Analyzers at All Blood Laboratories
-Contributing to Clean and Fair Sports Management by Enhancing the Quality of Doping Tests-
The OncoGuide™ NCC Oncopanel System Receives Insurance Coverage for Use in Cancer Genome Profiling
Sysmex and Osaka University Sign Comprehensive Collaboration Agreement to Foster Innovation in the Healthcare Field
Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 (PDF:389KB)
Sysmex Announces Changes from Financial Forecasts and Year-End Dividend for the Fiscal Year Ended March 31, 2019 (PDF:59KB)
Notice of the Booking of an Extraordinary Loss (Non-Consolidated) in Relation to an Affiliated Company (PDF:27KB)
Announcement Related to Granting of Stock Options (Stock Acquisition Rights) as a Part of Compensation to Members of the Managing Board (PDF:89KB)
Announcement of Executive Change (PDF:130KB)
Sysmex Announces New Group Mid-Term Management Plan
-Working to Enhance the Group’s Growth Potential and Reinforce the Management Base with a View to Sustainable Growth- (PDF:117KB)
Sysmex Opens Technopark East Site, a Bio-Diagnostic Reagent Base
-Strengthening Diagnostic Reagent Functions through an Integrated Structure from the Development of Substances to the Development, Production and Distribution of Bio-Diagnostic Reagents-
Promoting Business Process Restructuring through Digitalization to Reinforce Corporate Foundations and Create New Value
Sysmex Obtains CE Certification for Automated Hematology Analyzer XN-31, Which Has an Automatic Measurement Function for Red Blood Cells Infected by Malaria Parasites
-Contributing to the Early Detection and Treatment of Malaria through Standardized and More Efficient Malaria Testing-
Sysmex and Bayer Yakuhin Sign Memorandum of Understanding to Jointly Promote Open Innovation
-Start of Collaboration toward the Formation of an Ecosystem in the Life Science Field in Kobe-
Sysmex Launches Caresphere™ LWS, a Laboratory Information System
-Further Enhancing Clinical Testing Efficiency through a New Caresphere™ Solution-
Announcement of Organizational and Personnel Changes (PDF:322KB)
Sysmex to Be Special Sponsor of the Kobe Marathon 2019
-We are pleased to have sponsored this exciting event since its inception in 2011-
Commencement of Assay Service Using the OncoGuide™ NCC Oncopanel System in Cancer Genome Profiling
FY2018 Nakatani Award and Research Grant Recipients Announced (PDF:102KB)
Summary of Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending March 31, 2019 (PDF:381KB)
Sysmex and OPTiM Enter Alliance in the Area of “Advanced Medicine x AI and IoT”
-Accelerating Development and Deployment of IT Solutions and Platforms to Support Next-Generation Healthcare and Diagnostics-